DFTX vs. ENVB
DFTX (Definium Therapeutics, Inc) and ENVB (Enveric Biosciences Inc) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 3 years, DFTX returned 84.74%/yr vs -87.52%/yr for ENVB. At a 0.22 correlation, their price movements are largely independent.
Performance
DFTX vs. ENVB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DFTX achieves a 77.52% return, which is significantly higher than ENVB's -59.23% return.
DFTX
- 1D
- -3.96%
- 1M
- 13.24%
- YTD
- 77.52%
- 6M
- 96.77%
- 1Y
- 231.52%
- 3Y*
- 84.74%
- 5Y*
- —
- 10Y*
- —
ENVB
- 1D
- -3.27%
- 1M
- -34.22%
- YTD
- -59.23%
- 6M
- -72.39%
- 1Y
- -89.81%
- 3Y*
- -87.52%
- 5Y*
- -85.10%
- 10Y*
- -74.86%
DFTX vs. ENVB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
DFTX Definium Therapeutics, Inc | 77.52% | 92.39% | 90.16% | 66.36% | -78.74% |
ENVB Enveric Biosciences Inc | -59.23% | -94.37% | -72.43% | -37.50% | -82.78% |
Correlation
The correlation between DFTX and ENVB is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.15 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Jul 11, 2022 | 0.22 |
Fundamentals
DFTX:
$2.59B
ENVB:
$2.24M
DFTX:
-$2.57
ENVB:
-$10.60
DFTX:
9.27
ENVB:
0.44
DFTX:
$0.00
ENVB:
$0.00
DFTX:
$0.00
ENVB:
-$119.83K
DFTX:
-$206.36M
ENVB:
-$8.06M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DFTX vs. ENVB — Risk / Return Rank
DFTX
ENVB
DFTX vs. ENVB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Definium Therapeutics, Inc (DFTX) and Enveric Biosciences Inc (ENVB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DFTX | ENVB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +4.28 | ||
| Sortino ratioReturn per unit of downside risk | +4.86 | ||
| Omega ratioGain probability vs. loss probability | 1.45 | 0.87 | +0.58 |
| Calmar ratioReturn relative to maximum drawdown | 9.40 | -0.98 | +10.39 |
| Martin ratioReturn relative to average drawdown | 29.57 | -1.34 | +30.91 |
Loading charts...
Drawdowns
DFTX vs. ENVB - Drawdown Comparison
The maximum DFTX drawdown since its inception was -86.01%, smaller than the maximum ENVB drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for DFTX and ENVB.
Loading charts...
Drawdown Indicators
| DFTX | ENVB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -86.01% | -100.00% | +13.99% |
Max Drawdown (1Y)Largest decline over 1 year | -24.79% | -91.49% | +66.70% |
Max Drawdown (3Y)Largest decline over 3 years | -58.38% | -99.81% | +41.43% |
Max Drawdown (5Y)Largest decline over 5 years | — | -100.00% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -100.00% | — |
Current DrawdownCurrent decline from peak | -3.96% | -100.00% | +96.04% |
Average DrawdownAverage peak-to-trough decline | -51.17% | -86.07% | +34.90% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.88% | 66.73% | -58.85% |
Volatility
DFTX vs. ENVB - Volatility Comparison
The current volatility for Definium Therapeutics, Inc (DFTX) is 15.49%, while Enveric Biosciences Inc (ENVB) has a volatility of 21.07%. This indicates that DFTX experiences smaller price fluctuations and is considered to be less risky than ENVB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DFTX | ENVB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.49% | 21.07% | -5.58% |
Volatility (6M)Calculated over the trailing 6-month period | 39.04% | 105.59% | -66.55% |
Volatility (1Y)Calculated over the trailing 1-year period | 62.04% | 175.01% | -112.97% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 83.92% | 155.96% | -72.04% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 83.92% | 164.65% | -80.73% |
Dividends
DFTX vs. ENVB - Dividend Comparison
Neither DFTX nor ENVB has paid dividends to shareholders.
Financials
DFTX vs. ENVB - Financials Comparison
This section allows you to compare key financial metrics between Definium Therapeutics, Inc and Enveric Biosciences Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
DFTX and ENVB have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ENVB has higher volatility (21.07%) compared to DFTX (15.49%). In terms of maximum drawdown, DFTX dropped -86.01% vs ENVB's -100.00%.
DFTX currently has the higher Sharpe Ratio (3.76 vs -0.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DFTX and ENVB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer